LinkedIn automations are now retired. TexAu V3 is on the way, be the first to know when it launches.

Get updates

How Much Did Ruminant BioTech Raise? Headquarters, Funding & Key Investors

Ruminant BioTech has secured $33.7 million across Pre-Seed, Seed, and Series A rounds to advance its methane-reducing technologies for livestock. The company first raised $4.5M in 2022, followed by a $12.2M Seed round in May 2023 led by Regeneration.VC and Sturgess Holdings Ltd. Its Series A round of $17M in November 2025, led by Rosrain Investments and Cultivate Ventures, supports large-scale production and commercialization. With growing investor backing, Ruminant BioTech is rapidly scaling its environmental impact solutions for the agriculture sector.

    Ruminant BioTech develops agricultural biotechnology solutions aimed at reducing methane emissions from livestock. Its core innovation focuses on mitigating the environmental impact of ruminant animals by scientifically targeting methane formation within their digestive systems.

    The company serves farmers, agribusinesses, and environmental organizations seeking scalable, measurable solutions for climate-positive agriculture. Ruminant BioTech continues to expand research and commercialization efforts as global demand for sustainable food systems accelerates.

    What Is Ruminant BioTech and What Does It Do?

    Ruminant BioTech, founded in New Zealand, is an agriculture- and environment-focused biotech company. The company develops science-based solutions designed to significantly reduce methane emissions from ruminant livestock.

    Its technology leverages biological pathways to lower methane output, helping farmers improve sustainability performance while maintaining productivity.

    Ruminant BioTech employs between 11–50 employees, supporting product development, field testing, and commercialization efforts across global agriculture markets.

    How Much Funding Has Ruminant BioTech Raised?

    1. Pre-Seed

    • Amount Raised: $4.5 million
    • Motivation: To begin foundational research and validate methane-reduction technology in controlled environments.

    2. Seed Round

    • Amount Raised: $12.2 million
    • Lead Investors: Regeneration.VC, Sturgess Holdings Ltd
    • Motivation: To accelerate R&D, expand field trials, and establish early commercial partnerships.

    3. Series A

    • Amount Raised: $17 million
    • Lead Investors: Rosrain Investments, Cultivate Ventures
    • Motivation: To scale manufacturing, expand global deployment, and move toward commercial adoption.

    Total Funding Raised: $33.7 million

    Latest Funding Date: November, 2025

    Key Investors

    1. Regeneration.VC

    • Details: A climate-focused venture firm backing consumer- and planet-positive technologies.
    • Investment Focus Areas: Sustainability, climate tech, circular economy.
    • Notable Investments: Ruminant BioTech, CleanO2, LanzaTech.

    2. Sturgess Holdings Ltd

    • Details: A New Zealand-based investment firm supporting high-growth, impact-driven ventures.
    • Investment Focus Areas: Agritech, environment, emerging technologies.
    • Notable Investments: Ruminant BioTech, Zeffer, Fix & Fogg.

    3. Rosrain Investments

    • Details: An investment vehicle focused on advanced science-based climate solutions.
    • Investment Focus Areas: Environmental tech, biotech, sustainable agriculture.
    • Notable Investments: Ruminant BioTech, CarbonScape, AgriSea.

    4. Cultivate Ventures

    • Details: A venture fund specializing in agricultural innovation and food-system transformation.
    • Investment Focus Areas: Agritech, alternative proteins, climate resilience.
    • Notable Investments: Ruminant BioTech, MycoTechnology, New Culture.

    Where Is Ruminant BioTech’s Headquarters?

    Ruminant BioTech is headquartered in New Zealand, an emerging global hub for sustainable agriculture innovation. The country’s strong agritech ecosystem and access to large livestock farming populations provide a strategic testing ground for methane-reduction technologies.

    What’s Next for Ruminant BioTech?

    Ruminant BioTech aims to transition from pilot-stage deployments to large-scale commercial adoption. With new Series A capital, the company will expand production capacity, deepen field trials across New Zealand, Australia, and North America, and pursue regulatory approvals. As global climate targets tighten, Ruminant BioTech is positioned to become a key enabler of low-emission livestock systems.

    Get Investor & Funding Insights with TexAu 

    TexAu helps sales and business teams uncover detailed fundraising information on companies like Ruminant BioTech. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.


    Sign Up for Free on TexAu and start uncovering detailed funding insights that give your business a competitive edge.

    Start your 14-day free trial today, no card needed

    TexAu updates, tips and blogs delivered straight to your inbox.